221 related articles for article (PubMed ID: 36732495)
1. Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease.
Dong TS; Katzka W; Yang JC; Chang C; Arias-Jayo N; Lagishetty V; Balioukova A; Chen Y; Dutson E; Li Z; Mayer EA; Pisegna JR; Sanmiguel C; Jacobs JP
Gut Microbes; 2023; 15(1):2167170. PubMed ID: 36732495
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity.
Wang G; Wang Y; Bai J; Li G; Liu Y; Deng S; Zhou R; Tao K; Xia Z
Front Endocrinol (Lausanne); 2022; 13():1024769. PubMed ID: 36686492
[TBL] [Abstract][Full Text] [Related]
3. Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery.
Abu-Rumaileh M; Haddad RA; Yosef M; Esfandiari NH; Kraftson A; Khairi S; Lager C; Bushman J; Khalatbari S; Tincopa M; Varban O; Bozadjieva-Kramer N; Oral EA
Obes Surg; 2023 Dec; 33(12):3814-3828. PubMed ID: 37940737
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.
Pérez-Rubio Á; Soluyanova P; Moro E; Quintás G; Rienda I; Periañez MD; Painel A; Vizuete J; Pérez-Rojas J; Castell JV; Trullenque-Juan R; Pareja E; Jover R
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513605
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
[TBL] [Abstract][Full Text] [Related]
6. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
7. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
8. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
[TBL] [Abstract][Full Text] [Related]
9. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
[TBL] [Abstract][Full Text] [Related]
10. Links between gut microbiome, metabolome, clinical variables and non-alcoholic fatty liver disease severity in bariatric patients.
Schwenger KJP; Sharma D; Ghorbani Y; Xu W; Lou W; Comelli EM; Fischer SE; Jackson TD; Okrainec A; Allard JP
Liver Int; 2024 May; 44(5):1176-1188. PubMed ID: 38353022
[TBL] [Abstract][Full Text] [Related]
11. Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
Zhou H; Luo P; Li P; Wang G; Yi X; Fu Z; Sun X; Cui B; Zhu L; Zhu S
Obes Surg; 2022 Jun; 32(6):1872-1883. PubMed ID: 35386040
[TBL] [Abstract][Full Text] [Related]
12. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
13. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery.
Martínez-Montoro JI; Kuchay MS; Balaguer-Román A; Martínez-Sánchez MA; Frutos MD; Fernández-García JC; Ramos-Molina B
Obes Rev; 2022 Feb; 23(2):e13367. PubMed ID: 34729904
[TBL] [Abstract][Full Text] [Related]
15. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Fernández-Sáez EM; Losarcos M; Becerril S; Valentí V; Moncada R; Martín M; Burrell MA; Catalán V; Gómez-Ambrosi J; Mugueta C; Colina I; Silva C; Escalada J; Frühbeck G; Rodríguez A
Metabolism; 2023 Oct; 147():155663. PubMed ID: 37517791
[TBL] [Abstract][Full Text] [Related]
16. The effect of bariatric surgeries on nonalcoholic fatty liver disease.
Hassanian M; Al-Mulhim A; Al-Sabhan A; Al-Amro S; Bamehriz F; Abdo A; Al Khalidi H; Aldoheyan TA
Saudi J Gastroenterol; 2014; 20(5):270-8. PubMed ID: 25253361
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality.
Xia Y; Ren M; Yang J; Cai C; Cheng W; Zhou X; Lu D; Ji F
Front Microbiol; 2022; 13():1003755. PubMed ID: 36204626
[TBL] [Abstract][Full Text] [Related]
18. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
19. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
20. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
